Christopher Stevens
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Christopher Stevens is Chief Operating Officer at Rocket Pharmaceuticals, Inc. since 2025.
Formerly, Mr. Stevens was Chief Patent Supply Officer & Executive VP at Spark Therapeutics, Inc. from 2022 to 2025.
Education includes undergraduate studies at Purdue University and graduate studies at the University of Southern Indiana.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/02/2026 | 469.129 ( 0,43 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director de Operaciones | 07/07/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Indiana
University of Southern Indiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.